An official website of the United States government
          Here’s how you know
        Here’s how you know**Official websites use .gov**A
              **.gov** website belongs to an official government
              organization in the United States.
        **Secure .gov websites use HTTPS**A
              **lock** (
              Locked padlock icon) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
 Top Utility Nav
        
        
        Asian-Language Resources
        
        Portal en español


Site search Mega Menu
  

        

        Home
                  Health Topics
                                      
    
  Health Topics

    Arthritis and Rheumatic Diseases
          
    Muscle and Bone Diseases
          
    Skin Diseases
          
    All Diseases and Conditions
          
    Publication Catalog
                  Grants & Funding
                                      
    
  Grants & Funding

    Current Funding Opportunities
          
    Supported Scientific Programs
          
    NIAMS-Supported Programs
          
    Applying for a Grant
          
    NIH Policies and Guidance
          
    Peer Review and Grants Administration Resources
          
    Types of Funding Mechanisms (Activity Codes)
                  Labs @ NIAMS
                                      
    
  Labs @ NIAMS

    NIAMS Labs and Core Facilities
          
    Research Faculty
          
    Research Areas
          
    NIAMS Scientific Advances
          
    Training and Career Development
                  Clinical Trials
                                      
    
  Clinical Trials
      
            For Principal Investigators

    Clinical Trial Policies, Guidelines, and Templates
          
    Conducting Clinical Trials
          
    Register with ClinicalTrials.gov

For Patients

What is a Clinical Trial?
	Clinical Trials at NIAMS
	Clinical Trials in the Spotlight
                  News & Events
                                      
    
  Newsroom

    All NIAMS News
          
    NIAMS Newsletters
          
    Meetings & Events
                  About NIAMS
                                      
    
  About NIAMS

    Director's Page
          
    NIAMS Organization
          
    Strategic Plan Fiscal Years 2020-2024
          
    Staff Directory
          
    NIAMS Budget
          
    Partnerships
          
    Contact NIAMS
                  Community Outreach
                                      
    
  Community Outreach

    Bone Health
          
    Joint Health
          
    Muscle, Tendon, and Ligament Health
          
    Skin Health
          
    Health Information For Kids And Young Adults
          
    Health Information For Older Adults/Seniors
          
    Printable Materials for Community Events
          
    Resources in Other Languages
          
    Annual Health Observances
          
    Social Media Resources Breadcrumb
    Home
          Grants & Funding: The NIAMS Extramural Program
          SBIR/STTR FAQs








SBIR/STTR FAQs FacebookEmailPrintFacebookEmail     
    Funding Mechanisms Main Page
        
                  1. What are the NIAMS funding opportunities in the SBIR/STTR program?
      
  

    
      The NIAMS participates in the NIH Parent Announcement for the SBIR/STTR program (the omnibus solicitation of SBIR/STTR grant applications -- parent SBIR/STTR clinical trial not allowed).

PA-21-259: PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

PA-21-262: PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
PAR-21-030: Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)

PA-21-345: Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

RFA-NS-20-008: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)

RFA-NS-20-009: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)

RFA-NS-20-010: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)

RFA-NS-20-011: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)

PAR-20-128: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed)
PAR-20-129: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)

PAR-22-073: Innovation Corps (I-CorpsTM) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
      2. Where can I find an application guide?
      
  

    
      SF 424 (R&R) PDF Guide Application Guide for SBIR/STTR Grant Applications:https://grants.nih.gov/grants/how-to-apply-application-guide/forms-f/sbir-sttr-forms-f.pdf

Annotated Form Set for NIH Small Business (SBIR/STTR) Grant Applications:https://grants.nih.gov/grants/ElectronicReceipt/files/Annotated_Forms_SmallBus_FORMS-F.pdf
      3. I received a notification that my application was “Not Discussed”. What does that mean?
      
  

    
      Please review the description of the NIH review process. The peer review starts with three reviewers who evaluate the application by themselves and give an initial score. Then the review officer ranks all applications based on the average of the initial scores. On the review meeting day, the reviewers discuss the top half of the applications in the study section. Only those discussed applications receive an impact score. The undiscussed ones (bottom half) remain unscored and receive “Not Discussed” status. Every application will receive the reviewer’s critiques in the summary statement, which will be released normally within one month after the review. You can discuss it with the program officer if you have any questions.
      4. My application received an impact score. How do I know whether it may get funded or not?
      
  

    
      The NIAMS publishes SBIR/STTR paylines. If the impact score is within the payline, most likely it will get funded.
      5. Why did I receive a message saying my application submitted one year ago was not to be funded? I resubmitted my application. Is the resubmission going be affected?
      
  

    
      NIH is required by the law to notify the funding decisions on the SBIR/STTR applications within 12 months. Even though you knew your application was not going to be funded, NIH still needs to send out the notification within 12 months. The decision on an earlier application does not influence the funding consideration of later submissions.
      6. How do I request a no cost extension?
      
  

    
      No Cost Extensions may be performed automatically one-time only by the Signing Official (SO) no earlier than 90 days before the end of the project and no later than the end date. The SO should follow these steps to request ano cost extension.

Note: There can only be one no cost extension through Commons per grant. If you have applied previously for an extension for this grant, an Extension link will not be available.
      7. Does the SBIR/STTR program at NIAMS allow clinical trials?
      
  

    
      Unfortunately, the SBIR/STTR Program at NIAMS does not allow clinical trials. However, there are other grant mechanisms that NIAMS participates in that allow for clinical trials. Please see the following from the Grants and Funding/Types of Funding Mechanisms webpage on the NIAMS website that provides all the mechanisms that will permit clinical trials.
      8. Do you know if the award is taxable?  Or can you point me towards a source for this information.
      
  

    
      Applicants for and recipients of NIH grant funds, whether such funds are received through a grant, indirectly under a contract or consortium agreement, or by a fiscal agent acting on another organization’s behalf, or as student assistance under a training grant, are responsible for and must adhere to all applicable Federal statutes, regulations, and policies, including income tax regulations. Questions concerning the applicability of income tax regulations to grant funds should be directed to the IRS. The applicant also is expected to be in compliance with applicable State and local laws and ordinances.


Last Updated: May 2023


Back to Top
 About NIAMS
                    Clinical Trials
                    Grants & Funding
                    Health Topics
                    Labs @ NIAMS
              News Room
                    NIAMS Multimedia Library
                    Disclaimer
                    FOIA
                    Contact us
              Privacy Statement
                    Accessibility
                    HHS Vulnerability Disclosure
                    Social Media Moderation Policy
                    NIAMS Archives
        Subscribe to Our E-Newsletters
            Click the button to see different options to sign up for newsletters.
            Click Here to Subscribe
          Follow us on
  
  About NIH
                  Accessibility Support
            FOIA requests
                  No FEAR Act data
            Office of the Inspector General
                  Performance reports
            Privacy Policy